Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae

Journal of Clinical Microbiology

Volumn 54, Issue 3, 2016, Pages 805-808

  Hemarajata, P ^a   Yang, S ^a   Soge, O O ^b   Humphries, R M ^a   Klausner, J D ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING);

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; CONTROLLED STUDY; GENOTYPE; GYRA GENE; HUMAN; NEISSERIA GONORRHOEAE; NONHUMAN; POLYMERASE CHAIN REACTION SYSTEM; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; URINALYSIS; DRUG EFFECTS; GENETICS; GONORRHEA; ISOLATION AND PURIFICATION; MICROBIOLOGY; MUTATION;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CIPROFLOXACIN; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; GENOTYPE; GONORRHEA; HUMANS; MUTATION; NEISSERIA GONORRHOEAE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84959486552     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03032-15     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention. 2015. Sexually transmitted disease surveillance 2014. Centers for Disease Control and Prevention, Atlanta, GA.
2. Unemo M, Shafer WM. 2014. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: Past, evolution, and future. Clin Microbiol Rev 27:587-613. http://dx.doi.org/10.1128/CMR.00010-14.
3. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention, Atlanta, GA.
4. Centers for Disease Control and Prevention. 2012. Update to CDC's sexually transmitted diseases treatment guidelines, 2010: Oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 61:590-594.
5. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. 2015. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64(RR-03):1-137. http://dx.doi.org/10.15585/mmwr.rr6404a1.
6. Centers for Disease Control and Prevention. 2007. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: Fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 56:332-336.
7. Espinosa K, Park JA, Gerrity JJ, Buono S, Shearer A, Dick C, Mak ML, Teramoto K, Klausner JD, Pandori M, Hess D. 2015. Fluoroquinolone resistance in Neisseria gonorrhoeae after cessation of ciprofloxacin usage in San Francisco: Using molecular typing to investigate strain turnover. Sex Transm Dis 42:57-63. http://dx.doi.org/10.1097/OLQ.0000000000000233.
8. Siedner MJ, Pandori M, Castro L, Barry P, Whittington WL, Liska S, Klausner JD. 2007. Real-time PCR assay for detection of quinoloneresistant Neisseria gonorrhoeae in urine samples. J Clin Microbiol 45: 1250-1254. http://dx.doi.org/10.1128/JCM.01909-06.
9. CLSI. 2015. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement (M100-S25). Clinical and Laboratory Standards Institute, Wayne, PA.
10. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402. http://dx.doi.org/10.1093/nar/25.17.3389.
11. Goire N, Sloots TP, Nissen MD, Whiley DM. 2012. Protocol for the molecular detection of antibiotic resistance mechanisms in Neisseria gonorrhoeae. Methods Mol Biol 903:319-328. http://dx.doi.org/10.1007/978-1-61779-937-2-22.
12. Klausner JD, Kerndt P. 2013. Cephalosporin resistance in Neisseria gonorrhoeae infections. JAMA 309:1989. http://dx.doi.org/10.1001/jama .2013.4078.
13. Jenkins WD, Zahnd W, Kovach R, Kissinger P. 2013. Chlamydia and gonorrhea screening in United States emergency departments. J Emerg Med 44:558-567. http://dx.doi.org/10.1016/j.jemermed.2012.08.022.
14. Whiley DM, Goire N, Lahra MM, Donovan B, Limnios AE, Nissen MD, Sloots TP. 2012. The ticking time bomb: Escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother 67:2059-2061. http://dx.doi.org/10.1093/jac/dks188.
15. Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE, Melano RG. 2011. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob Agents Chemother 55:703-712. http://dx.doi.org/10.1128/AAC.00788-10.
16. Uehara AA, Amorin ELT, de Fátima Ferreira M, Andrade CF, Clementino MBM, de Filippis I, Neves FPG, Pinto TDCA, Teixeira LM, Giambiagi-deMarval M, Fracalanzza SEL. 2011. Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil. J Clin Microbiol 49:4208-4212. http://dx.doi.org/10.1128/JCM.01175-11.
17. Magooa MP, Muller EE, Gumede L, Lewis DA. 2013. Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay. Int J Antimicrob Agents 42:63-67. http://dx.doi.org/10.1016/j.ijantimicag.2013.02.026.
18. Endimiani A, Guilarte YN, Tinguely R, Hirzberger L, Selvini S, Lupo A, Hauser C, Furrer H. 2014. Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): Emergence of multidrugresistant clones less susceptible to cephalosporins. BMC Infect Dis 14:106. http://dx.doi.org/10.1186/1471-2334-14-106.
19. Nguyen D, Gose S, Castro L, Chung K, Bernstein K, Samuel M, Bauer H, Pandori M. 2014. Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins. Emerg Infect Dis 20:1211-1213.
20. Nicol M, Whiley D, Nulsen M, Bromhead C. 2015. Direct detection of markers associated with Neisseria gonorrhoeae antimicrobial resistance in New Zealand using residual DNA from the Cobas 4800 CT/NG NAAT assay. Sex Transm Infect 91:91-93. http://dx.doi.org/10.1136/sextrans-2014-051632.
21. Peterson SW, Martin I, Demczuk W, Bharat A, Hoang L, Wylie J, Allen V, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wong T, Mulvey MR. 2015. Molecular assay for detection of genetic markers associated with decreased susceptibility to cephalosporins in Neisseria gonorrhoeae. J Clin Microbiol 53:2042-2048. http://dx.doi.org/10.1128/JCM .00493-15.